Press release
Kaposi's Sarcoma Market Growing at a CAGR of around 6.3%
Kaposi's Sarcoma Market
The Kaposi's Sarcoma Market was valued at USD 980 million in 2024 and is projected to reach USD 1.82 billion by 2034, growing at a CAGR of around 6.3%. Growth is supported by rising HIV-associated cases in developing regions, better oncology care access, and expanded use of chemotherapeutic and immunomodulatory treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71228
Key Market Drivers
• Continued prevalence of HIV/AIDS, especially in low- and middle-income regions.
• Increased availability of HAART/ART therapy, reducing progression but increasing long-term patient survival.
• Growing use of chemotherapy (liposomal doxorubicin), interferon therapy, and emerging targeted approaches.
• Improvements in dermatology and oncology diagnostics, including biopsy, imaging, and PCR testing for HHV-8.
Challenges
• High burden of disease in regions with limited ART access.
• Late-stage presentation due to low awareness and delayed diagnosis.
• Limited treatment options for refractory or aggressive Kaposi's sarcoma.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/71228/kaposi-s-sarcoma-market
Market Segmentation
By Treatment
• Chemotherapy (liposomal doxorubicin, paclitaxel)
• Antiretroviral therapy (ART)
• Immunotherapy
• Radiation therapy
• Surgical/laser treatment (localized cases)
By Disease Type
• AIDS-associated Kaposi's Sarcoma
• Classic Kaposi's Sarcoma
• Endemic (African) Kaposi's Sarcoma
• Iatrogenic (immunosuppression-related) Kaposi's Sarcoma
By Diagnosis
• Skin/mucosal biopsy
• Imaging (CT/MRI/PET)
• HHV-8 testing
By End User
• Hospitals
• Cancer specialty centers
• Dermatology clinics
By Distribution Channel
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71228
Regional Snapshot
• North America shows stable demand with strong ART adoption and oncology infrastructure.
• Europe benefits from structured HIV care and availability of advanced chemotherapy options.
• Africa holds the highest disease burden, driving market need due to endemic and HIV-related cases.
• Asia-Pacific is growing as HIV care improves and oncology capacity expands.
Key Companies
Pfizer, Johnson & Johnson, Roche, Novartis, Bristol-Myers Squibb, Gilead Sciences, Merck & Co.
Future Outlook
Market growth will be shaped by expanding HIV/AIDS treatment programs, increasing availability of liposomal chemotherapies, and emerging targeted and immune-based therapies. Improving access to ART in high-burden regions will remain the most significant factor influencing long-term disease trends.
This report is also available in the following languages : Japanese (カポジ肉腫市場), Korean (카포시 육종 시장), Chinese (卡波西肉瘤市场), French (Marché du sarcome de Kaposi), German (Kaposi-Sarkom-Markt), and Italian (Mercato del sarcoma di Kaposi), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71228
Our More Reports:
Chronic Constipation Market
https://exactitudeconsultancy.com/reports/70945/chronic-constipation-market
Diabetes Insipidus Market
https://exactitudeconsultancy.com/reports/70947/diabetes-insipidus-market
Food Allergy Market
https://exactitudeconsultancy.com/reports/70949/food-allergy-market
Hypovolemic Shock Market
https://exactitudeconsultancy.com/reports/70951/hypovolemic-shock-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Kaposi's Sarcoma Market Growing at a CAGR of around 6.3% here
News-ID: 4311648 • Views: …
More Releases from Exactitude Consultancy
Penicillin-Binding Proteins (PBPs) Market is projected to reach USD 2.48 billion …
The global Penicillin-Binding Proteins (PBPs) Market was valued at USD 1.36 billion in 2024 and is projected to reach USD 2.48 billion by 2034, growing at a CAGR of 6.2% during 2025-2034. Growth is driven by increasing antimicrobial resistance (AMR), expanding research into β-lactam targets, rising demand for next-generation antibiotics, and technological advancements in structural biology and high-throughput screening.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70958
PBPs are essential…
Intraocular Lymphoma Market Growing at a CAGR of around 6.1%
Intraocular Lymphoma Market
The Intraocular Lymphoma Market was valued at USD 620 million in 2024 and is projected to reach USD 1.12 billion by 2034, growing at a CAGR of around 6.1%. Market growth is driven by increasing diagnosis of primary vitreoretinal lymphoma (PVRL), rising incidence of CNS-associated lymphomas, and wider adoption of targeted oncology treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71238
Key Market Drivers
• Growing recognition of primary intraocular…
Orthostatic Hypotension Market is projected to reach USD 1.95 billion by 2034
The global Orthostatic Hypotension (OH) Market was valued at USD 1.09 billion in 2024 and is projected to reach USD 1.95 billion by 2034, growing at a CAGR of 6.1% during 2025-2034. Growth is driven by an aging global population, increasing prevalence of neurodegenerative diseases, rising cases of autonomic dysfunction, improved diagnostic awareness, and growing adoption of pharmacologic and non-pharmacologic treatment options.
Download Full PDF Sample Copy of Market Report @…
Intraocular Lymphoma Market Growing at a CAGR of around 6.1%
Intraocular Lymphoma Market Overview
The Intraocular Lymphoma Market was valued at USD 620 million in 2024 and is projected to reach USD 1.12 billion by 2034, growing at a CAGR of around 6.1%. Market growth is driven by increasing diagnosis of primary vitreoretinal lymphoma (PVRL), rising incidence of CNS-associated lymphomas, and wider adoption of targeted oncology treatments.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71238
Key Market Drivers
• Growing recognition of primary intraocular…
More Releases for Kaposi
Kaposi Sarcoma Market forecast period 2023-2020
This Kaposi Sarcoma Market sector is rapidly evolving, with substantial growth and advancements expected by 2031. In-depth market research offers a comprehensive analysis of market size, share, and trends, providing crucial insights into its expansion. The report explores market segmentation and definitions, elucidating key components and drivers. Utilizing SWOT and PESTEL analyses, it evaluates the market's strengths, weaknesses, opportunities, and threats, as well as political, economic, social, technological, environmental, and legal factors.…
Kaposi Sarcoma Market : Current Trends & Opportunities by 2024
The global market for Kaposi sarcoma is highly consolidated in nature with two players holding a massive share of the market, states a new market intelligence study that’s has been recently published by Transparency Market Research. In 2015, the two leading players, namely Merck & Co. Inc. and Johnson & Johnson held a share of around 50% of the global market and is projected to remain in the similar situation…
Kaposi Sarcoma Treatment Market Drivers
Increasing number of patients undergoing organ transplant procedures is the leading cause for growth of the Kaposi sarcoma treatment market, as patients undergoing organ transplants are highly susceptible to this cancer. For instance, according to the National Kidney Foundation (NKF), in 2014, 17,107 kidney transplants took place in the U.S. Among which, 11,570 came from deceased donors and 5,537 came from living donors. Furthermore, increasing incidence of HIV/AIDS-associated Kaposi sarcoma…
Kaposi Sarcoma Market Research Report Forecast to 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market Research Report 2024
The global Kaposi sarcoma (KS) market is immensely consolidated and the top two players, namely Johnson & Johnson and Merck & Co. Inc. accounted for almost 50% of the overall market in 2015. The contribution of domestic players such as Sun Pharmaceutical Industries Limited is presented low. However, Transparency Market Research predicts that the contribution of these companies will increase during the forecast period owing to the patent expiry of…
Kaposi Sarcoma Market: Patent Expiry of Blockbuster Drugs for Treatment of Kapos …
Kaposi sarcoma is a soft tissue sarcoma that develops in connective tissues, blood vessels, fibrous tissues, and muscles. It is a malignant, multi-centric, neoplastic vascular proliferation, characterized by the development of bluish-red cutaneous nodules on the feet. According to the U.S. Center for Disease Control and Prevention (CDC), Kaposi sarcoma is considered an acquired immune deficiency syndrome (AIDS) defining disease. This report analyzes the current and future prospects of the…
